| Literature DB >> 24885898 |
Cai-Ling Lu, Shen Tang, Zhi-Juan Meng, Yi-Yuan He, Ling-Yong Song, Yin-Pin Liu, Ning Ma, Xi-Yi Li1, Song-Chao Guo.
Abstract
BACKGROUND: Excessive manganese exposure induced cognitive deficit. Several lines of evidence have demonstrated that taurine improves cognitive impairment induced by numerous neurotoxins. However, the role of taurine on manganese-induced damages in learning and memory is still elusive. This goal of this study was to investigate the beneficial effect of taurine on learning and memory capacity impairment by manganese exposure in an animal model.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24885898 PMCID: PMC4045917 DOI: 10.1186/1423-0127-21-51
Source DB: PubMed Journal: J Biomed Sci ISSN: 1021-7770 Impact factor: 8.410
Figure 1Evaluation of rat learning and memory in the Morris Water Maze. (A) Mean escape latency to the platform in the Morris water maze. (B) Mean swimming speed to the platform in the Morris water maze. (C) Mean cumulative distance in the Morris water maze. (D) Spatial memory retention in the Morris water maze probe trials among different groups. The test was conducted in the same way as the acquisition trials with the platform absent and 60s-trial limitation. The measure expressed is platform crossings ± S.E. Mn = 6-9. **p Mn versus control; *p < 0.05 versus Mn rats.
Figure 2Determination of manganese content in blood and the activity of acetylcholinesterase and choline acetyltransferase in hippocampus. (A) Mean blood manganese level for different treatment groups (n = 8). * p < 0.05 versus control rats. (B) The comparison of acetylcholinesterase and choline acetyltransferase activity among different treatment groups (n = 8).
Figure 3Examples of differentially expressed proteins in hippocampus found by 2-DE. (A) Representative 2D gel images from Mn and taurine + Mn. Molecular weight ranges from 250 KD to 10 KD and PIs ranges between 4 and 7. (B) Representative spots between the control and Mn treated groups. The control group as above line and 8w Mn administration group as below line. a(8C-M2):peroxiredoxin-6; b(8C-M8):dynactin subunit 3 isoform B; c(8C-M12):L-lactate dehydrogenase B chain.
9 identified viariation spots among different groups
| 8C-M 1 | Mu-crystallin homolog | gi|16758840 | 33533.1 | 5.34 | 100 |
| 8C-M 2 | Peroxiredoxin-6 | gi|16758348 | 24803 | 5.64 | 98.70 |
| 8C-M 3 | Actin-related protein 3 homolog | gi|161728791 | 47195.9 | 5.61 | 100 |
| 8C-M 4 | Calreticulin precursor | gi|11693172 | 47965.8 | 4.33 | 100 |
| 8C-M 5 | Secernin-1 | gi|68163565 | 46366.6 | 4.73 | 100 |
| 8C-M 8 | Dynactin subunit 3 isoform B | gi|227116275 | 17970.8 | 6.18 | 98.73 |
| 8C-M 12 | L-lactate dehydrogenase B chain | gi|6981146 | 36589.1 | 5.71 | 100.00 |
| 8 M-P 4 | Prepro-A-type allatostatin(N) | gi|152125945 | 15419.8 | 9.77 | 98.57 |
| 8 M-P 8 | Glial fibrillary acidic protein delta | gi|5030428 | 48752.2 | 5.72 | 100 |